Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent.

Trial Profile

Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 22 Dec 2012

At a glance

  • Drugs Prasugrel (Primary) ; Clopidogrel
  • Indications Cardiovascular disorders; Coronary artery disease; Coronary stent thrombosis
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms TACW; TRIGGER-PCI
  • Most Recent Events

    • 07 Jun 2012 Actual patient number changed from 426 to 423 as reported by ClinicalTrials.gov.
    • 21 Apr 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-004997-41).
    • 31 Mar 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top